Latest Insurance News

OM Holdings has cleared major regulatory hurdles in the $101 million sale of its 26% stake in Ntsimbintle Mining, moving closer to closing the deal in early 2026.

OM Holdings has secured key regulatory and shareholder approvals for the sale of its 26% interest in Ntsimbintle Mining, moving the $101 million transaction closer to completion early next year.

AUB Group has ended acquisition talks with EQT and CVC after the consortium declined to proceed with a $45 per share offer. The company reaffirms its FY26 earnings guidance and signals confidence in its organic growth strategy.

Cann Group Limited has announced a dramatic 81% reduction in core debt alongside a strategic pivot to higher-margin flower products, positioning the company for its first EBITDA-positive year in FY26.

Alliance Aviation Services reported record FY25 revenue and flying hours but faces margin pressures from rising costs and a major contract renegotiation. The company’s refreshed leadership is focused on operational improvements and debt reduction in FY26.

QBE Insurance Group reports sustained gross written premium growth of 6% for FY25 and announces a significant A$450 million on-market share buyback, reinforcing confidence in its financial outlook and capital management strategy.

Tower Limited has reported a record underlying profit for FY25, driven by improved claims ratios, customer growth, and strategic initiatives including expanded risk-based pricing. The insurer declared increased dividends and outlined a positive growth outlook for FY26.

Proteomics International secures a key Medicare reimbursement rate for its PromarkerD test, a predictive diagnostic for diabetic kidney disease, marking a critical step in its US commercial rollout.

Race Oncology Limited has secured shareholder approval for a replacement Constitution at its 2025 Annual General Meeting, updating its corporate governance framework to align with current regulatory standards.

Verbrec Limited reported record FY2025 financial results with its highest gross and adjusted EBITDA margins in years, alongside strategic moves including the acquisition of Alliance Automation and divestment of its Competency Training business.

Lumos Diagnostics has achieved a major milestone by securing 100% Medicare reimbursement recognition for its FebriDx test across all seven US Medicare Administrative Contractors, paving the way for broader adoption in the American healthcare system.

Emyria Limited is fast-tracking its national rollout of Empax mental health clinics, backed by a strong $8 million institutional placement and new dual-payer funding pathways.